Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy

By Parmiani Giorgio   Maccalli Cristina   Maio Michele  

Vaccines, Vol. 3, Iss. 2, 2015-05 ,pp. : 420-428

MDPI

Access to resources Recommend Favorite

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade

By Marchini Antonio   Scott Eleanor M.   Rommelaere Jean  

Viruses, Vol. 8, Iss. 1, 2016-01 ,pp. : 9-9

MDPI

Access to resources Recommend Favorite

Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T

By Yoon Dok Hyun   Osborn Mark J.   Tolar Jakub   Kim Chong Jai  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 340-340

MDPI

Access to resources Recommend Favorite

Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”

By Gelao Lucia   Criscitiello Carmen   Esposito Angela   Goldhirsch Aron   Curigliano Giuseppe  

Toxins, Vol. 6, Iss. 3, 2014-03 ,pp. : 914-933

MDPI

Access to resources Recommend Favorite

A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway Translational Blockade of Immune Checkpoints

By Li Yongshu   Li Fangfei   Jiang Feng   Lv Xiaoqing   Zhang Rongjiang   Lu Aiping   Zhang Ge  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1151-1151

MDPI

Access to resources Recommend Favorite